What is a ‘joint-flare’ and can it happen with 2.5% iPAAG (ArthramidVet®)?
Intraarticular injections in horses are beneficial for managing various musculoskeletal conditions, but they do come with associated risks and should be performed by a suitably qualified and experienced veterinarian. Furthermore,…
Recommendations and Safety of repeat dosing with 2.5% iPAAG ArthramidVet®
Introduction ArthramidVet® is a novel treatment and represents a paradigm shift in how veterinarians and owners think about treating lameness in horses. ArthramidVet® can be used in any joint that…
2023 North American Veterinary Regenerative Medicine Conference
Outrigger Kona Resort and Spa in Kona, Hawai’i September 22 – 24. Dr Jason Lowe presented his paper in a brief 15-minute talk. Histologic and cytologic changes in normal equine…
Combining the use of 2.5% PAAG and Corticosteroids
Introduction Treatments in horses due to osteoarthritis traditionally include rest, controlled exercise, corrective shoeing, nutraceuticals (including glucosamine, epiitalis, hyaluronic acid, and PSGAG’s), non-steroidal anti-inflammatory drugs (NSAID’s), and any combination of…
Management of subchondral bone disease in the equine fetlock joint
We recently met with experienced racetrack veterinarians’ that have introduced Arthramid Vet into their management of subchondral bone disease in racing Thoroughbreds’. Introduction: Subchondral bone is composed of a subchondral…
